ADVENTRX Pharmaceuticals (AMEX:ANX) is a company that is rarely mentioned among the bigger players, though this may soon change as it gains attention heading into its 2011 product pipeline catalysts. As it enters the new year, the stock seemed poised to make new 52-week highs as it announced the much anticipated positive 12-month results for [...]

Small cap biotech investments with upcoming FDA catalysts has become one of the hottest new trends, especially due to the fact that it is easy to foresee or expect catalysts based on the use of FDA calendars, and general medical timelines on drug and clinical trials. Unlike other industries where new technologies in research and [...]

Many investors, especially the bears that have been hiding for much of late 2010 and into 2011 will be smiling at the thoughts of a possible Wikileaks release to add fuel to the fire. Many sources are claiming Bank of America, however the way the economy has been the past few months, anything is possible [...]

As of today, I will begin a daily market update on the (note sarcasm) economic recovery and the USA’s ability to survive one of the worst depressions in history, because afterall, according to many experts we’ve now passed that phase. I felt the Austin Powers villain, Dr. Evil picture perfectly suits the overlods that run [...]

The stem cell market is slated to become $88.3 billion by 2014, with growth of well over 14.8% from now until then. This paves the way for potential revenues that border the imagination for any Wall Street analyst should any company become the first to see FDA approval. While at first thought this may sound [...]

Ever since The New York Stock Exchange building opened on April 22, 1903, it has flawlessly followed a particular pattern that, even to this day, still stands: hope, greed, skepticism, followed by, fear, panic, despondency whereby the pattern is once again repeated by beginning with hope. It is a cycle that can either make or [...]

In a day and age where uncertainty seems to rule the culture of the stock market world, call and put options have become increasingly popular in order to hedge a portfolio from a potential unforeseen event. Unfortunately, this is how most investors view options, however, many forget that it could also be used as a [...]

Within the $40 trillion dollar US market, the biotechnology sector has become a hot investment option for those looking to hedge against a possible upcoming market correction. During the past six months, shares within the NASDAQ Bio Index (NASDAQ:IBB) are up 20.12%, while the S&P Bio Index (NYSE:XBI) matched those gains with 21.02%. This is [...]

Following the Christmas break, shares of BioSante (NASDAQ:BPAX) soared more than 27% during Monday’s session on volume of 10.57M shares versus an average of 251,478, leaving investors hungry for the company’s potential in its upcoming FDA catalysts in early 2011, as highlighted by our previous article. All seemed well going into the next trading session, [...]

Below are a list of companies with exceptional chart patterns that are bound to bring high gains in the short-term: George Soros’ baby, Monsanto company, one that will reap tremendous benefits from the upcoming food inflation that is yet to be priced into markets around the world. With  an Inverse head and shoulders pattern that [...]